Impressum - Legal Notice

Published by:

The Executive Board of BRAIN Biotech AG
Darmstädter Straße 34 – 36
64673 Zwingenberg
Germany

Phone: +49 6251 9331-0
Fax: +49 6251 9331-11
Email: public@brain-biotech.com
Web: www.brain-biotech-group.com

Contact Investor Relations

Martina Schuster
Investor Relations
Phone: +49 6251 9331 69
Email: ir@brain-biotech.com

Contact Media

Dr. Stephanie Konle
PR & Corporate Communications
Phone: +49 6251 9331-70
Email: pr@brain-biotech.com

Concept and Realization

Editor: BRAIN Biotech AG Corporate Communications – Dr. Stephanie Konle
Design and technical implementation: RYZE Digital GmbH
Translation: Jonathan Spink

The publishers and editorial team would like to thank the many individuals who have worked together to prepare this report.

Publication date: 17 January 2024

Information

This report might contain certain forward-looking statements that are based on current assumptions and forecasts made by the management of the BRAIN Biotech Group and other currently available information. Various known and unknown risks and uncertainties as well as other factors can cause the company’s actual results, financial position, development or performance to diverge significantly from the estimates provided here. BRAIN Biotech AG does not intend and assumes no obligation of any kind to update such forward-looking statements and adapt them to future events or developments. The report can include information that does not form part of accounting regulations. Such information is to be regarded as a supplement to, but not a substitute for, information prepared according to IFRS. Due to rounding, it is possible that some figures in this and other documents do not add up precisely to the stated sum, and that stated percentages do not reflect the absolute figures to which they relate.
This document is a translation of a document prepared originally in German. Where differences occur, preference shall be given to the original German version.

Photo credits:

Photos in „Important events in the 2023/23 financial year“:
Sugar: blazny/stock.adobe.com,
Runner shoes: aprilian/stock.adobe.com,
Helix: peshkova/stock.adobe.com,
Business growth: Kiattisak/stock.adobe.com

As of: 17 January 2024